Filing Details
- Accession Number:
- 0001209191-21-055932
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-14 16:44:47
- Reporting Period:
- 2021-09-13
- Accepted Time:
- 2021-09-14 16:44:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1697532 | Applied Therapeutics Inc. | APLT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1775490 | Shoshana Shendelman | C/O Applied Therapeutics, Inc. 545 Fifth Avenue, Suite 1400 New York NY 10017 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-13 | 701 | $14.69 | 354,986 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-14 | 9,300 | $14.49 | 364,286 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,750,000 | Indirect | See footnote |
| Common Stock | 1,492,094 | Indirect | See footnote |
| Common Stock | 709,720 | Indirect | See footnote |
| Common Stock | 290,280 | Indirect | See footnote |
| Common Stock | 88,397 | Indirect | See footnote |
Footnotes
- These shares were purchased by Dr. Shendelman in multiple transactions.
- Weighted average price. These shares were purchased by Dr. Shendelman in multiple transactions at prices ranging from $14.6500 to $14.7300 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Weighted average price. These shares were purchased by Dr. Shendelman in multiple transactions at prices ranging from $14.2700 to $14.6000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Through a grantor retained annuity trust.
- Through a family trust controlled by the reporting person's spouse.
- Through the reporting person's spouse.
- Through a family trust controlled by the reporting person.
- Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.
Billionaire Hedge Funds
